首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance
【2h】

Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance

机译:趋化因子受体CXCR7在大肠癌中的表达及其预后意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have shown that chemokine receptor CXCR7 plays critical roles in tumor development. However, the clinicopathological and prognositic significance of CXCR7 in colorectal carcinoma (CRC) has not been fully understood. The aim of our study is to investigate the expression of CXCR7 and its clinical significance in CRC. First, quantitative RT-PCR and Western blot assays were performed to determine the expression of CXCR7 mRNA and protein in 20 paired of CRC tissues and corresponding adjacent non-tumor tissues. Next, immunohistochemistry was performed to detect the expression of CXCR7 protein in another 96 cases of CRC tissues, and analyze its correlation with clinicopathological factors of patients. Finally, the correlation of CXCR7 with 5-year overall survival (OS) and progression free survival (PFS) was statistically analyzed by the Kaplan-Meier method and Cox proportional hazards model. Results showed that the expression levels of CXCR7 mRNA and protein were significantly higher in CRC tissues than in normal tissues. Positive CXCR7 expression was observed to be significantly correlated with lymph nodal metastasis (P < 0.001), distant metastasis (P = 0.017), and advanced TNM stage (P < 0.001). Patients with positive expression of CXCR7 were demonstrated to be associated with worse OS and PFS (P < 0.001, P < 0.001, respectively). Moreover, multivariate survival analysis revealed that CXCR7 expression level might be an independent predictive factor for OS and PFS of CRC patients. Collectively, positive CXCR7 expression in CRC was correlated with tumor development and poor prognosis of patients.
机译:先前的研究表明,趋化因子受体CXCR7在肿瘤发展中起关键作用。但是,CXCR7在大肠癌(CRC)中的临床病理和预后意义尚未完全了解。我们研究的目的是研究CXCR7在CRC中的表达及其临床意义。首先,进行定量RT-PCR和Western印迹测定,以确定CXCR7 mRNA和蛋白在20对成对的CRC组织和相应的相邻非肿瘤组织中的表达。接下来,进行免疫组织化学检测另外96例CRC组织中CXCR7蛋白的表达,并分析其与患者临床病理因素的相关性。最后,通过Kaplan-Meier方法和Cox比例风险模型对CXCR7与5年总生存期(OS)和无进展生存期(PFS)的相关性进行了统计分析。结果表明,CRC组织中CXCR7 mRNA和蛋白的表达水平明显高于正常组织。观察到CXCR7阳性表达与淋巴结转移(P <0.001),远处转移(P = 0.017)和晚期TNM分期(P <0.001)显着相关。 CXCR7表达阳性的患者被证明与OS和PFS较差有关(分别为P <0.001,P <0.001)。此外,多因素生存分析表明,CXCR7表达水平可能是CRC患者OS和PFS的独立预测因素。总的来说,CRC中CXCR7阳性表达与肿瘤发展和患者预后不良相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号